Agilent Technologies, Inc. A
172.79
(0.05)
(0.03%)
as of 25 Sep
- Market cap
- $49.0B
- P/E
- 33.9×
Follow A
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Agilent Technologies, Inc. (A) Operating cash flow
Agilent Technologies, Inc.'s operating cash flow for fiscal 2025 was $1.6B, down 11.0% from $1.8B in fiscal 2024. Over the twelve months to 31 July 2026 it was $1.6B. Over the past ten years it has ranged from $512.0M (fiscal 2015) to $1.8B (fiscal 2023); the current reading is higher than 82% of that period. Agilent Technologies, Inc. ranks 6th of 52 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Annual
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $1.6B | (10.97%) |
| FY2024 | $1.8B | (1.19%) |
| FY2023 | $1.8B | 35.06% |
| FY2022 | $1.3B | (11.65%) |
| FY2021 | $1.5B | 61.24% |
| FY2020 | $921.0M | (9.79%) |
| FY2019 | $1.0B | (6.07%) |
| FY2018 | $1.1B | 22.27% |
| FY2017 | $889.0M | 12.11% |
| FY2016 | $793.0M | 54.88% |
Quarterly
| Period | Operating cash flow | Change |
|---|---|---|
| Jul 2026 | $519.0M | 87.36% |
| Apr 2026 | $277.0M | 3.36% |
| Jan 2026 | $268.0M | (50.83%) |
| Oct 2025 | $545.0M | 50.55% |
| 43 more quarters | Free account |
Against its own ten years
Low $512.0M
High $1.8B
Ten-year median
$1.1B
Current reading's percentile
82
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| IQV IQVIA Holdings Inc. compare | $2.8B |
| DGX Quest Diagnostics Incorporated compare | $1.9B |
| A Agilent Technologies, Inc. | $1.6B |
| IDXX IDEXX Laboratories, Inc. compare | $1.4B |
| ILMN Illumina, Inc. compare | $1.1B |
| MTD Mettler-Toledo International, Inc. compare | $975.2M |
| WAT Waters Corporation compare | $549.6M |
| NTRA Natera, Inc. compare | $228.2M |
| GH Guardant Health, Inc. compare | −$185.2M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on A
- Revenue
- Net income
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement